Huber; Monica J.

Patent Applications and Registrations

Patent applications and USPTO patent grants for Huber; Monica J..The latest application filed is for "treating inflammation with il-17/il-23 bispecific antibodies".

Company Profile

1.13.12

Huber; Monica J. - Bothell WA
Huber; Monica J. - Mill Creek WA

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Treating inflammation with IL-17/IL-23 bispecific antibodies Grant 10,562,967 - Lewis , et al. Feb	2020-02-18
Treating Inflammation With Il-17/il-23 Bispecific Antibodies App 20180251541 - Lewis; Katherine E. ; et al.	2018-09-06
Polynucleotides Encoding Monoclonal Antibodies That Bind Both Il-17a And Il-17f App 20180251543 - Jaspers; Stephen R. ; et al.	2018-09-06
Monoclonal antibodies that bind both IL-17A and IL-17F Grant 10,000,563 - Jaspers , et al. June 19, 2	2018-06-19
Use of an IL-17/IL-23 bispecific antibody for treating inflammation Grant 9,994,634 - Lewis , et al. June 12, 2	2018-06-12
Use Of An Il-17/il-23 Bispecific Antibody For Treating Inflammation App 20160376362 - Lewis; Katherine E. ; et al.	2016-12-29
Monoclonal Antibodies That Bind Both Il-17a And Il-17f App 20160311897 - Jaspers; Stephen R. ; et al.	2016-10-27
Polynucleotides encoding antagonists of IL-17A, IL-17F, and IL-23p19 Grant 9,464,134 - Lewis , et al. October 11, 2	2016-10-11
Methods of treating inflammatory diseases using antibodies that bind both IL-17A and IL-17F Grant 9,416,183 - Jaspers , et al. August 16, 2	2016-08-16
Polynucleotides Encoding Antagonists Of Il-17a, Il-17f, And Il-23p19 App 20150197566 - Lewis; Katherine E. ; et al.	2015-07-16
Antagonists of IL-17A, IL-17F, and IL-23P19 Grant 8,992,922 - Lewis , et al. March 31, 2	2015-03-31
Methods Of Treating Inflammatory Diseases Using Antibodies That Bind Both Il-17a And Il-17f App 20150010553 - JASPERS; STEPHEN R. ; et al.	2015-01-08
Polynucleotides encoding antibodies that bind both IL-17A and IL-17F Grant 8,871,467 - Jaspers , et al. October 28, 2	2014-10-28
Antagonists Of Il-17a, Il-17f, And Il-23p19 App 20130309235 - Lewis; Katherine E. ; et al.	2013-11-21
Polynucleotides Encoding Antibodies That Bind Both Il-17a And Il-17f App 20130288304 - Jaspers; Stephen R. ; et al.	2013-10-31
Polynucleotides encoding antibodies that bind both IL-17A and IL-17F Grant 8,557,544 - Jaspers , et al. October 15, 2	2013-10-15
Antagonists of IL-17A, IL-17F, and IL-23P19 Grant 8,496,936 - Lewis , et al. July 30, 2	2013-07-30
Methods of inhibiting inflammation with antagonists to IL-17A, IL-17F, and IL-23P19 Grant 8,333,968 - Lewis , et al. December 18, 2	2012-12-18
Antagonists Of Il-17a, Il-17f, And Il-23p19 App 20120294862 - Lewis; Katherine E. ; et al.	2012-11-22
Methods Of Inhibiting Inflammation With Antagonists To Il-17a, Il-17f, And Il-23p19 App 20110159589 - Lewis; Katherine E. ; et al.	2011-06-30
Antagonists to IL-17A, IL-17F, and IL-23P19 and methods of use Grant 7,910,703 - Lewis , et al. March 22, 2	2011-03-22
Treatment Of Aplastic Anemia App 20100008917 - Hosken; Nancy ; et al.	2010-01-14
Antagonists To Il-17a, Il-17f, And Il-23p19 And Methods Of Use App 20080299129 - Lewis; Katherine E. ; et al.	2008-12-04

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.